共 160 条
[1]
Khalaf N(2021)Burden of pancreatic cancer: from epidemiology to practice Clin Gastroenterol Hepatol : Off Clin Pract J Am Gastroenterol Assoc 19 876-84
[2]
El-Serag HB(2020)Cancer statistics, 2020 CA: Cancer J Clin 70 7-30
[3]
Abrams HR(2014)Pancreatic adenocarcinoma New Engl J Med. 371 1039-49
[4]
Thrift AP(2013)The clinical utility of CA 19–9 in pancreatic adenocarcinoma: diagnostic and prognostic updates Curr Mol Med. 13 340-51
[5]
Siegel RL(2019)Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer J Gastroenterol. 54 19-32
[6]
Miller KD(2015)Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals World J Gastrointest Endosc. 7 833-42
[7]
Jemal A(2020)Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer Nat Rev Gastroenterol Hepatol 17 153-68
[8]
Ryan DP(2019)Clinical utility of circulating tumor DNA for colorectal cancer Cancer Sci. 110 1148-55
[9]
Hong TS(2015)Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility Clin Cancer Res: Off J Am Assoc Cancer Res 21 4786-800
[10]
Bardeesy N(2006)Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA Pancreas. 32 171-7